These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17898017)

  • 1. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006.
    Stern M; Wiedemann B; Wenzlaff P;
    Eur Respir J; 2008 Jan; 31(1):29-35. PubMed ID: 17898017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a cystic fibrosis patient registry to assess outcomes and improve cystic fibrosis care in Germany.
    Stern M
    Curr Opin Pulm Med; 2011 Nov; 17(6):473-7. PubMed ID: 21881513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the US and Australian cystic fibrosis registries: the impact of newborn screening.
    Martin B; Schechter MS; Jaffe A; Cooper P; Bell SC; Ranganathan S
    Pediatrics; 2012 Feb; 129(2):e348-55. PubMed ID: 22250024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease.
    Efrati O; Mei-Zahav M; Rivlin J; Kerem E; Blau H; Barak A; Bujanover Y; Augarten A; Cochavi B; Yahav Y; Modan-Moses D
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):222-8. PubMed ID: 16456419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The German cystic fibrosis quality assurance project: clinical features in children and adults.
    Wiedemann B; Steinkamp G; Sens B; Stern M;
    Eur Respir J; 2001 Jun; 17(6):1187-94. PubMed ID: 11491163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benchmarking to evaluate the care of patients with cystic fibrosis: an established tool to improve patient care].
    Niemann N; Wenzlaff P; Stern M
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(5):354-9. PubMed ID: 21767793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mucoviscidosis quality assurance. Problems, success and prospects 1995-1998].
    Stern M; Sens B; Wiedemann B
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):513-9. PubMed ID: 9842699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation.
    Snell GI; Bennetts K; Bartolo J; Levvey B; Griffiths A; Williams T; Rabinov M
    J Heart Lung Transplant; 1998 Nov; 17(11):1097-103. PubMed ID: 9855449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
    Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
    Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales.
    McKay KO; Waters DL; Gaskin KJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S47-50. PubMed ID: 16202782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can health-related quality of life predict survival in adults with cystic fibrosis?
    Abbott J; Hart A; Morton AM; Dey P; Conway SP; Webb AK
    Am J Respir Crit Care Med; 2009 Jan; 179(1):54-8. PubMed ID: 18948427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Danish version of the revised cystic fibrosis quality of life questionnaire in adolescents and adults (CFQ-R14+).
    Bregnballe V; Thastum M; Lund LD; Hansen CR; Preissler T; Schiøtz PO
    J Cyst Fibros; 2008 Nov; 7(6):531-6. PubMed ID: 18694658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use].
    Schöni-Affolter F; Oswald P; Wandt-Baumann C; Kriemler S; Schöni MH
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1373-81. PubMed ID: 11059028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of care and clinical condition in paediatric cystic fibrosis patients.
    Baumann U; Stocklossa C; Greiner W; von der Schulenburg JM; von der Hardt H
    J Cyst Fibros; 2003 Jun; 2(2):84-90. PubMed ID: 15463855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmarking improves quality in cystic fibrosis care: a pilot project involving 12 centres.
    Stern M; Niemann N; Wiedemann B; Wenzlaff P;
    Int J Qual Health Care; 2011 Jun; 23(3):349-56. PubMed ID: 21504960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre.
    Dijk FN; McKay K; Barzi F; Gaskin KJ; Fitzgerald DA
    Arch Dis Child; 2011 Dec; 96(12):1118-23. PubMed ID: 21994242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.
    Boyle MP; Sabadosa KA; Quinton HB; Marshall BC; Schechter MS
    BMJ Qual Saf; 2014 Apr; 23 Suppl 1():i15-i22. PubMed ID: 24608546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth during puberty in cystic fibrosis: a retrospective evaluation of a French cohort.
    Bournez M; Bellis G; Huet F
    Arch Dis Child; 2012 Aug; 97(8):714-20. PubMed ID: 22692018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.